Unicep competitors

Zippia score 4.1

Unicep main competitors are CPR Website, P. J. Noyes, and HTI.

Competitor Summary. See how Unicep compares to its main competitors:

Qualitest Pharmaceuticals has the most employees (7,500).
Employees at CPR Website earn more than most of the competitors, with an average yearly salary of $65,113.

Work at Unicep?

Share your experience

Unicep vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Unicep	1991	4.1	Sandpoint, ID	2	$40.6M	100
Universal Packaging Systems Inc	1987	4.2	Chino, CA	1	$86.0M	125
Aphena Pharma Solutions	2002	4.2	Cookeville, TN	2	$9.5M	107
Aaron Industries	-	3.9	Clinton, SC	1	$13.9M	200
PL Developments	1988	4.6	Westbury, NY	6	$1.4B	3,000
Ambu USA	1937	3.8	Glen Burnie, MD	2	$69.0M	5,000
HTI	-	4.3	Powell, OH	1	$211.7M	10
CPR Website	1996	4.1	Greensboro, NC	1	$14.0M	17
Rockwell Medical	1996	4.2	Wixom, MI	1	$101.5M	269
HUMCO	1872	3.9	Texarkana, TX	2	$45.2M	100
North Safety Products L.L.C.	1973	4.6	Cranston, RI	1	$320.0M	1,050
Cadista Pharmaceuticals	2005	4.6	Salisbury, MD	1	$75.0M	200
Axygen	1993	3.7	Union City, CA	1	$240,000	200
Best Formulations	1984	4.4	Industry, CA	1	$30.0M	121
Qualitest Pharmaceuticals	1983	4.1	Huntsville, AL	1	$230.0M	7,500
PCI Pharma Services	2012	4.1	Philadelphia, PA	2	$260.0M	1,679
P. J. Noyes	1868	3.4	Lancaster, NH	1	$870,000	7

Rate Unicep's competitiveness in the market.

Unicep salaries vs competitors

Among Unicep competitors, employees at CPR Website earn the most with an average yearly salary of $65,113.

Compare Unicep salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Unicep	$64,966	$31.23	-
Universal Packaging Systems Inc	$48,963	$23.54	-
Aphena Pharma Solutions	$50,277	$24.17	-
Aaron Industries	$42,075	$20.23	-
PL Developments	$42,659	$20.51	-
Ambu USA	$46,278	$22.25	-

Compare Unicep job title salaries vs competitors

Company	Highest salary	Hourly salary
Unicep	$70,550	$33.92
Rockwell Medical	$81,609	$39.24
Qualitest Pharmaceuticals	$75,205	$36.16
Cadista Pharmaceuticals	$71,368	$34.31
PL Developments	$70,810	$34.04
CPR Website	$70,736	$34.01
Universal Packaging Systems Inc	$70,728	$34.00
Ambu USA	$70,706	$33.99
P. J. Noyes	$70,677	$33.98
HTI	$70,660	$33.97
PCI Pharma Services	$70,571	$33.93
HUMCO	$70,571	$33.93
North Safety Products L.L.C.	$70,539	$33.91
Best Formulations	$70,503	$33.90
Aaron Industries	$70,385	$33.84
Aphena Pharma Solutions	$70,167	$33.73
Axygen	$67,173	$32.29

Do you work at Unicep?

Is Unicep able to compete effectively with similar companies?

Unicep jobs

Unicep demographics vs competitors

Compare gender at Unicep vs competitors

Job title	Male	Female
PCI Pharma Services	54%	46%
Cadista Pharmaceuticals	56%	44%
HTI	58%	42%
PL Developments	63%	37%
Rockwell Medical	67%	33%
Unicep	-	-

Male

Female

100%

75%

50%

25%

Unicep

Rockwell Medical

PL Developments

HTI

Cadista Pharmaceuticals

PCI Pharma Services

25%

50%

75%

100%

Compare race at Unicep vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Rockwell Medical	63%	14%	13%	7%	3%	9.6
PCI Pharma Services	66%	14%	11%	6%	3%	8.4
PL Developments	52%	24%	13%	8%	3%	8.3
HTI	64%	10%	17%	6%	3%	9.7
Cadista Pharmaceuticals	49%	11%	22%	14%	5%	8.6

Unicep and similar companies CEOs

CEOBio

Russell H. Ellison

Rockwell Medical

Dr. Ellison has served as our President and Chief Executive Officer since April 2020 and as a Director on our Board since January 2020. Dr. Ellison’s broad experience and leadership positions include Chief Executive Officer of the privately held biotechnology company, Promedior, Inc. (acquired by Roche); President and Chief Executive Officer of Bond Biosciences, Inc., a biotech start-up developing a drug addressing the toxic impact of iron overload in the body; Executive Director of Torreya Advisors, LLC, a life sciences investment banking firm; Chairman and Chief Executive Officer of Assembly Biosciences, Inc. (formerly Ventrus Biosciences, Inc.); Executive Vice President of Paramount Biosciences LLC, a global drug development and healthcare investment firm; Vice President of Clinical Development of FibroGen, Inc., where he played a key role in the early phase development of roxadustat in anemia for chronic kidney disease (CKD) patients; Vice President of Medical Affairs and Chief Medical Officer of Sanofi-Synthelabo US, Inc.; and Vice President, Medical Affairs and Chief Medical Officer of Hoffman La Roche, Inc. in the United States. Dr. Ellison previously served as an Independent Board Director for several private and public companies, including Cougar Biotechnology Inc.; ProSanos Corporation; Cormedix Inc., a cardio-renal clinical stage company; and Mt. Cook, a urology-focused company. Dr. Ellison received a Master of Science degree from the London School of Tropical Medicine and Hygiene, and an M.D. from the University of British Columbia.

Britt Meelby Jensen

Ambu USA

Salim Haffar

PCI Pharma Services

Salim Haffar has been President of Aptar Pharma since January 2014. Previously, he served as President of Aptar Pharma's Prescription Division and Co-President of Valois Group and President of Valois' Pharma division. Prior to 2008, Salim held various sales and marketing positions within the Company's Valois Pharma division in France.

Mitch Singer

PL Developments

Christophe Devins

HTI

Gregory Pulido

HUMCO

Gregory Pulido is a Chairman and Chief Executive Officer at HUMCO and is based in Austin, Texas. He studied at Arizona State University.

Shawn Reilley

Aphena Pharma Solutions